|
End-of-day quote
Amman S.E.
2026-08-23
|
5-day change | 1st Jan Change | ||
| 1.840 JOD | 0.00% |
|
-7.07% | +15.00% |
| 07-21 | Philadelphia Pharmaceuticals Company Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-27 | Philadelphia Pharmaceuticals Q1 profit 255,632 dinars | RE |
Stock exchange
Amman S.E.
PHIL 1.840 JOD
0.00%
421.36
JOD
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| PHIL | 1.840JOD | 0.00% | 421.36 JOD |
Quotes 5-day view: Philadelphia Pharmaceuticals Company
End-of-day quote Amman S.E.| 2026-08-20 | 2026-08-23 | |
|---|---|---|
| Last | JOD 1.840 | JOD 1.840 |
| Volume | 371 | 229 |
| Change | - | 0.00% |
| Opening | JOD 1.870 | JOD 1.840 |
| High | JOD 1.870 | JOD 1.840 |
| Low | JOD 1.840 | JOD 1.840 |
Performance
| 1 week | -7.07% | ||
| Current month | -8.00% | ||
| 1 month | -8.00% | ||
| 3 months | +6.98% | ||
| 6 months | +18.71% | ||
| Current year | +15.00% | ||
| 1 year | +26.03% | ||
| 3 years | +29.58% | ||
| 5 years | +33.33% | ||
| 10 years | -39.67% |
Volumes
marketsDaily volume
229
Avg. Volume 20 sessions
737
Avg. Volume 20 sessions JOD
1,356.08
Avg. Volume 20 sessions USD
1,916.18
Record volume 1
2,992,594
Record volume 2
2,211,594
Record volume 3
1,536,403
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (JOD)
13,800,000
Market Cap (USD)
19,477,770
Net sales ()
9,169,000
Net sales (USD)
12,941,426
Number of employees
129
Sales / Employee (JOD)
71,078
Sales / Employee (USD)
100,321
Free-Float
7.27 %
Free-Float capitalization (JOD)
1,003,260
Free-Float capitalization (USD)
1,416,034
Average Daily Capital Traded
0.01%
Indicators
Moving average 5 days
1.93
Moving average 20 days
1.85
Moving average 50 days
1.66
Moving average 100 days
1.56
Price spread / (MMA5)
+4.89%
Price spread / (MMA20)
+0.54%
Price spread / (MMA50)
-9.78%
Price spread / (MMA100)
-15.22%
RSI 9 days
44.64
RSI 14 days
53.41
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -7.07% | +26.03% | +29.58% | 19.48M | |
| +0.02% | +1.12% | +14.87% | +70.18% | 47.71B | |
| +0.33% | +1.83% | +52.56% | +123.63% | 40.3B | |
| -0.92% | -0.88% | -11.39% | +16.26% | 12.09B | |
| -1.08% | -2.02% | +8.36% | +73.00% | 11.68B | |
| +0.19% | +0.58% | +30.98% | +158.71% | 9.19B | |
| -0.39% | -0.92% | +20.49% | +38.72% | 7.57B | |
| -0.45% | +1.12% | +46.23% | -11.95% | 7.24B | |
| -0.16% | -0.52% | +18.45% | +209.28% | 6.84B | |
| -5.36% | -6.36% | -38.04% | +22.49% | 5.42B | |
| Average | -0.77% | -1.85% | +16.85% | +72.99% | 14.81B | |
| Weighted average by Cap. | -0.28% | -0.57% | +23.52% | +85.09% |
Historical Quotes: Philadelphia Pharmaceuticals Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 1.84 |  | 1.87 |
| 1 month | 1.84 | | 2.01 |
| Current year | 1.5 | | 2.01 |
| 1 year | 1.48 | | 2.01 |
| 3 years | 1.36 | | 2.01 |
| 5 years | 1.28 | | 2.01 |
| 10 years | 1.28 | | 3.19 |
Monthly variations
Annual variations
| 2026 | +15.00% | ||
| 2025 | +6.67% | ||
| 2024 | +4.90% | ||
| 2023 | +2.88% | ||
| 2022 | +1.46% | ||
| 2021 | -4.20% | ||
| 2020 | -8.33% | ||
| 2019 | -1.27% | ||
| 2018 | +1.94% | ||
| 2017 | -29.86% | ||
| 2016 | -27.30% | ||
| 2015 | -6.06% | ||
| 2014 | +405.63% | ||
| 2013 | +153.97% | ||
| 2012 | -20.25% | ||
| 2011 | -16.84% | ||
| 2010 | -45.40% |
- Stock Market
- Stocks
- PHIL Stock
- Quotes Philadelphia Pharmaceuticals Company
Select your edition
All financial news and data tailored to specific country editions
